Press Release: European Medicines Agency’s Scientific Coordination Board starts reflection on best cooperation between scientific committees

The European Medicines Agency (EMA), in April 2012, formally launched its new Scientific Coordination Board. The mission of the group will be to ensure that there is sufficient coordination between the Agency's committees, so that the standards they set for the development of medicines are consistent across the whole product life-cycle, for increased robustness and predictability of benefit-risk assessment. The Board will meet four times a year.

EMA: Press Release: EMA/274306/2012 (24.4.12): European Medicines Agency’s Scientific Coordination Board starts reflection on best cooperation between scientific committees http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2012/04/WC500126142.pdf

---